PublicaciĂłn:
4TH BOOSTER-DOSE SARS-COV-2 HETEROLOGOUS AND HOMOLOGOUS VACCINATION IN RHEUMATOLOGICAL PATIENTS

Vista sencilla de Ă­tem
dc.creatorYOLANDA MAGALY GĂ“MEZ OLMOS
dc.date2024
dc.date.accessioned2025-01-10T15:51:27Z
dc.date.available2025-01-10T15:51:27Z
dc.date.issued2024
dc.description.abstractTO EVALUATE THE IMMUNE RESPONSE TO THE SARS-COV-2 VACCINES IN ADULTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES (IMRDS) IN COMPARISON TO HEALTHY INDIVIDUALS, OBSERVED 1-20 WEEKS FOLLOWING THE FOURTH VACCINE DOSE. ADDITIONALLY, TO EVALUATE THE IMPACT OF IMMUNOSUPPRESSIVE THERAPIES, VACCINATION SCHEDULES, THE TIME INTERVAL BETWEEN VACCINATION AND SAMPLE COLLECTION ON THE VACCINE?S IMMUNE RESPONSE. PERFORMING A COMPARISON BETWEEN THE VARIANTS, WUHAN VS OMICRON, WE NOTICED THAT THERE WERE SIGNIFICANT DIFFERENCES (P
dc.formatapplication/pdf
dc.identifier.doi10.3389/fimmu.2024.1427501
dc.identifier.issn1664-3224
dc.identifier.issn1664-3224
dc.identifier.urihttps://repositorio.ubiobio.cl/handle/123456789/13976
dc.languagespa
dc.publisherFrontiers in Immunology
dc.relation.uri10.3389/fimmu.2024.1427501
dc.rightsPUBLICADA
dc.subjectSARS-CoV-2
dc.subjectimmunosuppressive therapies
dc.subjecthumoral IgG
dc.subjectCOVID-19 vaccines
dc.subjectautoimmune rheumatic diseases
dc.title4TH BOOSTER-DOSE SARS-COV-2 HETEROLOGOUS AND HOMOLOGOUS VACCINATION IN RHEUMATOLOGICAL PATIENTS
dc.typeARTĂŤCULO
dspace.entity.typePublication
ubb.EstadoPUBLICADA
ubb.Otra ReparticionDEPARTAMENTO DE ESTADISTICA
ubb.SedeCONCEPCIĂ“N
Archivos
Colecciones
ArtĂ­culos cientĂ­ficos